News and Updates

New research highlights how paternal health before conception shapes offspring development, signaling a paradigm shift in reproductive medicine and diagnostics.

Explore the latest research on brain waste clearance and its implications for the $20B neurodegenerative disease market and future therapeutic developments.

Analyzing the clinical and regulatory implications of Retatrutide for GLP-1 muscle loss and the risks of off-label prescribing in the obesity treatment market.

Experts advocate rebranding PCOS to PMOS to address metabolic dysregulation. Explore the implications for diagnostic protocols, pharma R&D, and clinical pathways.